These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5711745)

  • 1. [Clinical study of a low dosage estrogen-progestational combination (FH 027-A)].
    Villedieu P
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):329-36. PubMed ID: 5711745
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with ethynodiol diacetate combined with mestronal (metrulen).
    McGoogan LS
    Nebr State Med J; 1968 Jul; 53(7):341-3. PubMed ID: 4232054
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of a new estrogen-progestational combination at low doses in gynecologic therapy].
    Seassaro E
    Quad Clin Ostet Ginecol; 1969 Jun; 24(6):385-97. PubMed ID: 5398761
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 9. SC11800 sequential paper.
    Tompkins MG
    Fertil Steril; 1970 Jan; 21(1):77-9. PubMed ID: 5411039
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
    Fiorino S; Rossi T; Scio A
    Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
    [No Abstract]   [Full Text] [Related]  

  • 11. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol].
    Colin R
    Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
    Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
    Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled rhythm: an analysis of 88 cycles.
    Lorenzo CL; Sturgis SH
    Fertil Steril; 1968; 19(4):490-9. PubMed ID: 5660237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double blind test for induction of uterine hemorrhage by Ovulen (ethynodiol diacetate 0.5mg+mestranol 1.1mg])].
    Tanaka Y
    Sanfujinka No Jissai; 1970 Aug; 19(8):877-80. PubMed ID: 4917962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our clinical experience with an ovulostatic estro-progestative combination in weak doses].
    Letessier A; Koressios J
    Gynecol Prat; 1968; 19(3):189-96. PubMed ID: 5720359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
    Willmes HG
    Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oral contraception and gynecologic therapy].
    Käsemann W
    Med Welt; 1969 Jan; 2():107-10. PubMed ID: 4179615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M
    Gynecol Prat; 1966; 17():337-43. PubMed ID: 5987259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.